Undisclosed NCE
Cancer and Neurodegenerative Diseases (e.g., Bipolar Disorder)
Phase 2Entering Phase II Efficacy Studies
Key Facts
Indication
Cancer and Neurodegenerative Diseases (e.g., Bipolar Disorder)
Phase
Phase 2
Status
Entering Phase II Efficacy Studies
Company
About Intas Pharmaceuticals
A leading global pharmaceutical company developing and manufacturing generics, biosimilars, and complex injectables across oncology, cardiovascular, and neuroscience.
View full company profile